{"DataElement":{"publicId":"3121742","version":"1","preferredName":"Patient Central Nervous System Disease or Disorder Eligibility Determination Ind-3b","preferredDefinition":"an indicator that can have a value of yes, no, or not applicable related to eligibility criteria for person who receives medical attention, care, or treatment having disease related to the brain and spinal cord.","longName":"2974446v1.0:2958018v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2974446","version":"1","preferredName":"Patient Central Nervous System Disease or Disorder Eligibility Determination","preferredDefinition":"information related to eligibility criteria for person who receives medical attention, care, or treatment having disease related to the brain and spinal cord.","longName":"2233604v1.0:2974444v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2974478","version":"1","preferredName":"Central Nervous System Disease or Disorder Eligibility Determination","preferredDefinition":"The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Criteria to determine eligibility of patients for medical care programs and services.","longName":"C12438:C2991:C25171","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-F208-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"GOG CRF:Gynecologic Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD9A2C7-351D-7BDB-E040-BB89AD432FAC","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-12-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506036","version":"1","preferredName":"Yes No Not Applicable Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no/not applicable.","longName":"YES_NO_NA_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"14","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not Applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"3261243","version":"1","preferredName":"Not Applicable","longName":"3261243","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA2BBD66-6581-A6F2-E040-BB89AD4311D3","latestVersionIndicator":"Yes","beginDate":"2011-08-10","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-08-10","modifiedBy":"RAGUNATHANU","dateModified":"2024-02-05","changeDescription":"12/15/15 added N/A as alternate VM-tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-759A-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75A4-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-7590-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2694966","version":"1","preferredName":"Ind-3b","preferredDefinition":"A response or indicator that can have a value of yes, no, or not applicable.","longName":"C49797","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes, No, or Not Applicable Response","conceptCode":"C49797","definition":"A response or indicator that can have a value of yes, no, or not applicable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"3EBCA780-282F-4411-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-12","endDate":"2016-04-27","createdBy":"CURTIST","dateCreated":"2007-11-12","modifiedBy":"TAYLORT","dateModified":"2020-10-02","changeDescription":"10.2.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Retired DBW 04-27-2016 per Tina Taylor approved by Dianne Reves","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-757C-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ZHANGWE","dateModified":"2019-01-24","changeDescription":"3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. 8/3/2015 Corrections made to VD in order to restore to original format: removed C49486 as rep term and replaced with C49797; restored long name and definition per Dianne Reeves/tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"3303197","version":"1","longName":"Phase 1/Pilot Consortium","context":"COG"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"10000287","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"4104909","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"10000288","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"10000172","version":"1","longName":"GOG-0241","context":"NRG"},{"publicId":"4104913","version":"1","longName":"GOG-0241","context":"NRG"},{"publicId":"10000693","version":"1","longName":"GOG-9923","context":"NRG"},{"publicId":"4104931","version":"1","longName":"GOG-9923","context":"NRG"},{"publicId":"10000692","version":"1","longName":"GOG-9923","context":"NRG"},{"publicId":"4104917","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"10000174","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"10000175","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"10000281","version":"1","longName":"GOG-0280","context":"NRG"},{"publicId":"10000282","version":"1","longName":"GOG-0280","context":"NRG"},{"publicId":"4104929","version":"1","longName":"GOG-0280","context":"NRG"}]},{"publicId":"4254096","version":"1","longName":"Protocol Phase","context":"PBTC","ClassificationSchemeItems":[{"publicId":"10000103","version":"1","longName":"Phase I","context":"PBTC"},{"publicId":"4254119","version":"1","longName":"PBTC-042","context":"PBTC"}]}],"AlternateNames":[{"name":"2974446v1.0:2958018v1.0","type":"USED_BY","context":"CTEP"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"PtHxCNSDxIND","type":"COG GDE Short Name","context":"COG"},{"name":"GOG","type":"USED_BY","context":"NRG"},{"name":"2974446v1.0:2958018v1.0","type":"USED_BY","context":"COG"},{"name":"2974446v1.0:2958018v1.0","type":"USED_BY","context":"NRG"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"SEIZ_ON_THERAPY","type":"Context Short Name","context":"NRG"},{"name":"INT_SEIZ_ON_THERAPY","type":"Context Short Name","context":"NRG"}],"ReferenceDocuments":[{"name":"Does the patient have a histo","type":"Preferred Question Text","description":"Does the patient have a history or evidence upon physical examination of CNS disease, including primary brain tumor, seizures not controlled with standard medical therapy, any brain metastases, or history of cerebrovascular accident (CVA, stroke), transient ischemic attack (TIA) or subarachnoid hemorrhage within six months of the first date of treatment on this study?","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Known central nervous system or brain metastasis that are either symptomatic or untreated","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Does the patient have a history or evidence upon physical examination of CNS disease, including brain tumor, seizures not controlled with standard medical therapy or any brain metastases?","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Known CNS metastases or seizure disorder","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Does the patient have a history of active seizures, i.e., seizures within the last 12 months?","url":null,"context":"CTEP"},{"name":"COG_CRF_Text_1","type":"Alternate Question Text","description":"Does patient have a history of metastatic CNS disease","url":null,"context":"CTEP"},{"name":"CRF Text6","type":"Alternate Question Text","description":"Does the patient have seizures or have a history of seizures?","url":null,"context":"CTEP"},{"name":"COG_CRF_Text_2","type":"Alternate Question Text","description":"Does the patient have a history of CNS Disease","url":null,"context":"CTEP"},{"name":"AECC Text 1","type":"Alternate Question Text","description":"Does patient have a history of brain metastases?","url":null,"context":"AECC"},{"name":"AECC Text  2","type":"Alternate Question Text","description":"If patient has history of seizure disorder, has patient had a seizure episode within the last 6 months? (N/A only if patient does not have history of seizure disorder)","url":null,"context":"AECC"},{"name":"NRG_CRF Text","type":"Alternate Question Text","description":"Does the patient have a history or evidence upon physical examination of CNS disease, including primary brain tumor, seizures or history of seizures, and/or CNS metastases?","url":null,"context":"NRG"},{"name":"GOG_CRF Text","type":"Alternate Question Text","description":"Does the patient have a history or evidence upon physical examination of CNS disease, including primary brain tumor, seizures not controlled with standard medical therapy, any brain metastases or a history of stroke within 5 years of the first date of treatment on this study?","url":null,"context":"NRG"},{"name":"PBTC_Text2","type":"Alternate Question Text","description":"Does patient have a history of recurrent, progressive or refractory central nervous system (CNS) tumor?","url":null,"context":"PBTC"},{"name":"PBTC_Text1","type":"Alternate Question Text","description":"Does patient have DIPG or other centrally confirmed Rb1 positive recurrent, progressive or refractory central nervous system (CNS) tumor?","url":null,"context":"PBTC"},{"name":"PBTC_Text5","type":"Alternate Question Text","description":"Does patient have histologic verification of a primary CNS tumor at original diagnosis or at relapse? The requirement for histological verification is waived in patients with DIPG (Diffuse Intrinsic Pontine Glioma).","url":null,"context":"PBTC"},{"name":"CRF Text 7","type":"Alternate Question Text","description":"Intractable seizures while on adequate anticonvulsant therapy-more than 1 seizure per month for the past 2 months","url":null,"context":"NRG"},{"name":"PBTC-Text3","type":"Alternate Question Text","description":"Does patient have a diagnosis of recurrent or refractory primary CNS malignancy (excluding low-grade gliomas)?","url":null,"context":"PBTC"},{"name":"PBTC_Text6","type":"Alternate Question Text","description":"Does the patient have DIPG with atypical presentation on MRI which has been confirmed by biopsy?","url":null,"context":"PBTC"},{"name":"PBTC_Text7","type":"Alternate Question Text","description":"For patients with DIPG who have undergone a biopsy, does the patient have a diagnosis of high-grade glioma or diffuse infiltrating glioma?","url":null,"context":"PBTC"},{"name":"CRF_Text_12","type":"Alternate Question Text","description":"Does the patient have active seizure disorder uncontrolled by medication?","url":null,"context":"CTEP"},{"name":"CRF Text 13","type":"Alternate Question Text","description":"Does the patient have asymptomatic untreated CNS disease","url":null,"context":"CTEP"},{"name":"CRF Text 14","type":"Alternate Question Text","description":"Does the patient have asymptomatic untreated or treated CNS disease","url":null,"context":"CTEP"},{"name":"PBTC_Text8","type":"Alternate Question Text","description":"Does the patient have evidence of intact Rb1 protein from a CLIA certified laboratory?","url":null,"context":"PBTC"},{"name":"CRF Text 16","type":"Alternate Question Text","description":"Does the patient have asymptomatic untreated CNS metastases?","url":null,"context":"CTEP"},{"name":"PBTC_Text4","type":"Alternate Question Text","description":"Does the patient have a recurrent, progressive or refractory primary CNS tumor with evidence of genetic activation of the MET pathway, regardless of histology?","url":null,"context":"PBTC"},{"name":"CRF Text 18","type":"Alternate Question Text","description":"Does CNS disease demonstrate evidence of stabilization after the 28 day time point after definitive treatment?","url":null,"context":"CTEP"},{"name":"CRF Text 17","type":"Alternate Question Text","description":"Does the patient have CNS disease?","url":null,"context":"CTEP"},{"name":"NRG_eCRF_Text","type":"Alternate Question Text","description":"Does the patient have known primary central nervous system (CNS) malignancy or CNS metastasis?","url":null,"context":"NRG"},{"name":"PBTC_Text9","type":"Alternate Question Text","description":"Does patient have histologically confirmed medulloblastoma that is recurrent or progressive?","url":null,"context":"PBTC"},{"name":"CITN Text","type":"Alternate Question Text","description":"If patient has had prior brain metastases or CNS disease, are the following criteria met: treatment is completed and either (1) has no evidence of active CNS disease for at least 4 weeks prior to the first dose OR (2) has stable CNS lesions, or be at least 2 weeks past radiation or gamma-knife therapy.Â  Patients with past CNS disease must also have a Screening head CT or MRI demonstrating stable disease compared to their most recent CNS evaluation.","url":null,"context":"CITN"},{"name":"NRG_eCRF_Text_1","type":"Alternate Question Text","description":"Does the patient have asymptomatic treated CNS disease?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_2","type":"Alternate Question Text","description":"Does the patient have active seizure disorder uncontrolled by medication?","url":null,"context":"NRG"},{"name":"PBTC_Text10","type":"Alternate Question Text","description":"Does the patient have evidence of reactivity for B7H3 (CD276) from a CLIA certified laboratory?","url":null,"context":"PBTC"},{"name":"PBTC_Text 11","type":"Alternate Question Text","description":"Does the patient have an H3K27M positive Thalamic Diffuse Midline Glioma?","url":null,"context":"PBTC"},{"name":"NRG_eCRF_Text_3","type":"Alternate Question Text","description":"Does the patient have an active seizure disorder uncontrolled by medication?","url":null,"context":"NRG"},{"name":"PBTC_Text12","type":"Alternate Question Text","description":"Does patient have a histologically confirmed diagnosis of Medulloblastoma that is recurrent or progressive?","url":null,"context":"PBTC"},{"name":"NRG CRF Text 1","type":"Alternate Question Text","description":"Does the participant have a history of stroke, traumatic brain injury, brain surgery, Alzheimer's disease or other dementia?","url":null,"context":"NRG"}],"origin":"GOG CRF:Gynecologic Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8B6A7F53-48F0-0AD5-E040-BB89AD433968","latestVersionIndicator":"Yes","beginDate":"2010-07-15","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-15","modifiedBy":"TSESU","dateModified":"2023-09-06","changeDescription":"Replaced VD Assessments Ind-3b 2958018v1 with VD ID#3506036 - Yes No Not Applicable Indicator - dbw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}